Furthermore, understanding the involvement of IL-1α in the pathologic process of periodontitis could guide the development of targeted therapeutic interventions, such as anti-inflammatory agents or personalized treatment strategies tailored to the genetic profiles of individuals or specific population groups [27]. This evidence concerns the gene IL1A and periodontitis.